Colon Cancer Pharmaceutical and Healthcare Pipeline Review H1
Aug 21, 2017
Pune, India,21st August 2017: WiseGuyReports announced addition of new report, titled “Colon Cancer Global Clinical Trials Review, H1, 2017”.
Pune, India - August 21, 2017 /MarketersMedia/ —
Summary
“Colon Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Colon Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Colon Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/1793454-colon-cancer-global-clinical-trials-review-h1-2017
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Table of Content: Key Points
Table of Contents 2
List of Tables 4
List of Figures 5
Report Guidance 6
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Colon Cancer to Oncology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Colon Cancer to Oncology Clinical Trials 20
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 28
Subjects Recruited Over a Period of Time 29
…Continued
ACCESS REPORT @ https://www.wiseguyreports.com/reports/1793454-colon-cancer-global-clinical-trials-review-h1-2017
Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts
Contact Info:
Name: NORAH TRENT
Email: [email protected]
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Pune - 411028 Maharashtra, India
Phone: +44 208 133 9349
Source URL: http://marketersmedia.com/colon-cancer-pharmaceutical-and-healthcare-pipeline-review-h1/231251
For more information, please visit http://www.wiseguyreports.com
Source: MarketersMedia
Release ID: 231251
More News
![aritcles[0].caption](https://images.perthnow.com.au/publication/C-22939324/b11b69fcad92ab7d8975c335d0d5a169863fd3b9-16x9-x0y192w2048h1152.jpg)
JoJo wore 'busty' outfit to MTV VMAs after major wardrobe malfunction
JoJo has revealed her original outfit choice for the MTV Video Music Awards "literally broke and disintegrated".
Olivia Rodrigo designer explains how dissolving dress works
The designer behind Olivia Rodrigo's dissolving dress has explained how it works - revealing the gown she debuted on The Unraveled Tour is made from a "special paper-like material" which melts away when it comes into contact with water.
Congo's Ebola outbreak tops 8000 confirmed cases
Ebola cases remain out of control in Congo, surging past 8000 as the African nation struggles to field enough health workers to contain the disease.
We arrested an abusive offender. After five minutes in a cell, his demeanour completely transformed
I’ve dealt with plenty of criminals. Mostly the bad ones because they’re easier to catch.
HDT sold to Bathurst winner ahead of major announcement
The Holden Dealer Team, synonymous with iconic Aussie racing driver Peter Brock, has now changed hands.
Next-generation Mitsubishi Delica firms for Australia
Mitsubishi’s popular people mover is looking more likely for the Australian market, following a recent local trademark submission from the brand.
Psychologists want in on early intervention program
Children and families could miss out on vital early support if the new Thriving Kids program doesn't use the expertise of Australian psychologists.
New BYD Atto 1 revealed: Australia’s cheapest EV gets bigger
The second-generation BYD Atto 1 electric hatchback will be larger, more powerful and offer five seats when it goes on sale in China later this year.
Mercedes-Benz may follow Volkswagen's lead with factory closures – report
The world's oldest automaker is feeling the crunch of Chinese-market losses and US tariffs, with job cuts and plant closures reportedly on the table.
Research debunks mental health link to daylight saving
As millions of Australians prepare for the clocks to jump forward, researchers say there is no evidence the change causes major mental health declines.
BYD targets fleet buyers to bolster sales growth
BYD has proved popular with private buyers in Australia, and now the Chinese brand is keen on expanding its presence in the fleet market.
BYD confirms pricing for Australia's cheapest EV won't last forever
BYD may offer the most affordable electric car in Australia right now, but it concedes it won't once the Atto 1's drive-away discount expires.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.